Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.

Leave a Reply

Your email address will not be published. Required fields are marked *